1. Effect of Postdismissal Pharmacist Visits for Patients Using High-Risk Medications 
Joseph R. Herges, PharmD, BCPS, Lori B. Herges, PharmD, BCPS, Ross A. Dierkhising, MS, Kristin C. Mara, MS, Amanda Z. Davis, PharmD, BCACP, Kurt B. Angstman, MD 
Mayo Clinic Proceedings: Innovations, Quality & Outcomes  
Volume 2, Issue 1, Pages 4-9 (March 2018)
DOI: /j.mayocpiqo
Copyright © 2017 Mayo Foundation for Medical Education and Research Terms and Conditions

2. Figure
Cumulative incidence of readmission. Kaplan-Meier curves estimating the incidence of readmission after follow-up visit for the PCC group and the UC group. PCC = pharmacist and clinician collaborative; UC = usual care.
Mayo Clinic Proceedings: Innovations, Quality & Outcomes  2018 2, 4-9DOI: ( /j.mayocpiqo )
Copyright © 2017 Mayo Foundation for Medical Education and Research Terms and Conditions